27th May 2025 18:16
Smith & Nephew PLC - Watford, England-based medical equipment provider - Wins 10-year contracted worth up to USD75 million from the US Department of Defense to provide its Renasys Touch negative pressure wound therapy system. "The system will support military medical providers to administer therapy through prolonged casualty care, first surgical intervention, aeromedical transport and definitive care in military treatment facilities," company says. The solution is manufactured in the US. The deal complements Smith+Nephew's master cooperative research and development agreement with the US Army Institute of Surgical Research for wound and burn care.
"Future conflicts will be more difficult and complex. This implies medical devices and treatments will need to be simplified and more intuitive to be used farther forward by a wide range of providers. Renasys Touch NPWT will provide that simplified negative pressure wound therapy solution to the military care continuum for warfighters who need it most," says Dennis Lyons, senior director of Military & Federal Health at Smith+Nephew.
Current share price: 1,070.25p, closed up 0.7% in London on Tuesday
12-month change: up 9.2%
By Aidan Lane, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved
Related Shares:
Smith & Nephew